Last reviewed · How we verify
Ibuprofen 5% topical gel
At a glance
| Generic name | Ibuprofen 5% topical gel |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children (PHASE3)
- Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS (PHASE2)
- Effects of Low Level Laser Therapy On Exercise Induced Muscle Damage in Wrist Flexors Of Untrained Young Adults (NA)
- Topical Ibuprofen for Delayed Onset Mulscle Soreness (PHASE3)
- Ultrasound-Guided Erector Spinae Plan Block in Patients Undergoing ESWL (NA)
- Ibuprofen Gel or Capsaicin Cream for my Painful Knee Osteoarthritis? (NA)
- Phase II Study of AP0302 5% Versus a Vehicle Comparator (PHASE2)
- 5% Topical Ibuprofen (IBU) for Ankle Sprain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ibuprofen 5% topical gel CI brief — competitive landscape report
- Ibuprofen 5% topical gel updates RSS · CI watch RSS
- Pfizer portfolio CI